Clinical impact and 'natural' course of uncorrected tricuspid regurgitation after implantation of a left ventricular assist device: an analysis of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS)

Autor: Ad J.J.C. Bogers, Theo M M H de By, Kadir Caliskan, Paul Mohacsi, Euromacs Investigators, M. Mostafa Mokhles, Ivan Netuka, Felix Schoenrath, Osama Ibrahim Ibrahim Soliman, Johanna J.M. Takkenberg, Lech Paluszkiewicz, Kevin M Veen
Přispěvatelé: Cardiothoracic Surgery, Cardiology
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
medicine.medical_treatment
Left ventricular assist device
Tricuspid regurgitation
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Tricuspid Valve Insufficiency
Internal medicine
medicine
Humans
Registries
Eacts/118
Mortality
Retrospective Studies
Natural course
Heart Failure
Tricuspid valve
AcademicSubjects/MED00920
business.industry
Eacts/173
Hazard ratio
Transplantation and Mechanical Circulatory Support
General Medicine
Middle Aged
equipment and supplies
medicine.disease
Pulmonary hypertension
Treatment Outcome
medicine.anatomical_structure
030228 respiratory system
Ventricular assist device
Concomitant
Circulatory system
Cardiology
Surgery
Heart-Assist Devices
Elevated right atrial pressure
Cardiology and Cardiovascular Medicine
business
Eacts/125
Zdroj: European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 59(1), 207-216. Elsevier
ISSN: 1873-734X
1010-7940
Popis: OBJECTIVES Data on the impact and course of uncorrected tricuspid regurgitation (TR) during left ventricular assist device (LVAD) implantation are scarce and inconsistent. This study explores the clinical impact and natural course of uncorrected TR in patients after LVAD implantation. METHODS The European Registry for Patients with Mechanical Circulatory Support was used to identify adult patients with LVAD implants without concomitant tricuspid valve surgery. A mediation model was developed to assess the association of TR with 30-day mortality via other risk factors. Generalized mixed models were used to model the course of post-LVAD TR. Joint models were used to perform sensitivity analyses. RESULTS A total of 2496 procedures were included (median age: 56 years; men: 83%). TR was not directly associated with higher 30-day mortality, but mediation analyses suggested an indirect association via preoperative elevated right atrial pressure and creatinine (P = 0.035) and bilirubin (P = 0.027) levels. Post-LVAD TR was also associated with increased late mortality [hazard ratio 1.16 (1.06–1.3); P = 0.001]. On average, uncorrected TR diminished after LVAD implantation. The probability of having moderate-to-severe TR immediately after an implant in patients with none-to-mild TR pre-LVAD was 10%; in patients with moderate-to-severe TR pre-LVAD, it was 35% and continued to decrease in patients with moderate-to-severe TR pre-LVAD, regardless of pre-LVAD right ventricular failure or pulmonary hypertension. CONCLUSIONS Uncorrected TR pre-LVAD and post-LVAD is associated with increased early and late mortality. Nevertheless, on average, TR diminishes progressively without intervention after an LVAD implant. Therefore, these data suggest that patient selection for concomitant tricuspid valve surgery should not be based solely on TR grade.
Databáze: OpenAIRE